53 products found

LIAISON®ANTI-HAV

310200

Intended Use For the qualitative detection of total IgG and IgM antibodies to Hepatitis A virus
Material provided Reagent integral for 100 determinations. Diluent included.
Method 2-step sandwich chemiluminescent immunoassay using directly coated magnetic microparticles
Calibrators Included
Sample Type Serum or Na+ Heparin plasma
Sample Size 80 µL
Comments In Vitro Diagnostic Use

LIAISON®Control Anti-HAV

310201

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® HAV IgM

310210

Intended Use For the qualitative detection of IgM antibodies to Hepatitis A virus
Material provided Reagent integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic micropartles
Calibrators Included
Sample Type Serum or Na+ Heparin plasma
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control HAV IgM

310211

Material provided Two levels x 2 vials each 15 determinations per vial

LIAISON® Rubella IgG

310460

Intended Use For the qualitative determination of IgG antibodies to Rubella virus
Material provided Reagent integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic micropartles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Rubella IgG Tri-Controls

310461

Material provided Three levels x 2 vials each 15 determinations per vial

LIAISON® Rubella IgM

310730

Intended Use For the qualitative determination of IgM antibodies to Rubella virus
Material provided Reagent Integral for 100 determinations. Diluent included
Method Antibody capture immunoassay using coated magnetic microparticles
Calibrators Included
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control Rubella IgM

310732

Material provided Two levels x 2 vials each, 20 determinations total

LIAISON® Treponema Assay

310480

Intended Use For the qualitative determination of total antibodies to Treponema pallidum
Material provided Reagent Integral for 200 determinations. Diluent included
Method 1-step chemiluminescent immunoassay using coated magnetic microparticles
Calibrators Included
Incubation 30 minutes
Sample Type Serum
Sample Size 70 µL
Comments In Vitro Diagnostic Use

LIAISON® VZV IgG

310490

Intended Use For the qualitative determinations of IgG antibodies to Varicella-Zoster Virus
Material provided Reagent Integral for 50 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control VZV IgG

310491

Material provided Two levels x 2 vials each 20 determinations per vial

LIAISON® EBV IgM

310500

Intended Use For the qualitative determination of IgM antibodies to Epstein-Barr virus viral capsid antigen
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control EBV IgM

310501

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON®VCA IgG

310510

Intended Use For the qualitative determination of IgG antibodies to Epstein-Barr Virus Viral Capsid Antigen (VCA)
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic mircroparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control VCA IgG

310511

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® EBNA IgG

310520

Intended Use For the qualitative determination of IgG antibodies to Epstein-Barr Virus Nuclear Antigen (EBNA-1)
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic mircroparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control EBNA IgG

310521

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® EA IgG

310540

Intended Use For the qualitative determination of IgG antibodies to Epstein-Barr Virus Early Antigen (Diffuse) [EA(d)]
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using directly coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control EA IgG

310541

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® HSV-2 Type Specific IgG

310620

Intended Use For the qualitative determination of type specific IgG antibodies to Herpes Simplex Virus Type 2 (HSV-2)
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using directly coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 5 µL
Comments In Vitro Diagnostic Use

LIAISON® Control HSV-2 Type Specific IgG

310621

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® Toxo IgG II

310705

Intended Use For the qualitative determination of IgG antibodies to Toxoplasma gondii
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control Toxo IgG II

310706

Material provided Two levels x 2 vials each 24 determinations

LIAISON® Toxo IgM II

310715

Intended Use For the qualitative determination of IgM antibodies to Toxoplasma gondii
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using directly coated magnetic microparticles
Calibrators Included
Incubation 25 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control Toxo IgM II

310716

Material provided Two levels x 2 vials each 24 determinations

LIAISON® CMV IgG

310740

Intended Use For the qualitative determination of IgG antibodies to Cytomegalovirus
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control CMV IgG

310741

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® CMV IgM

310750

Intended Use For the qualitative determination of IgM antibodies to Cytomegalovirus
Material provided Reagent integral for 100 determinations. Diluent included.
Method 3-step chemiluminescent immunoassay using directly coated magnetic microparticles
Calibrators Included
Incubation 30 minutes
Sample Type Serum
Sample Size 20 µL
Comments In Vitro Diagnostic Use

LIAISON® Control CMV IgM

310751

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® HSV-1 Type Specific IgG

310830

Intended Use For the qualitative determination of type specific IgG antibodies to Herpes Simplex Virus Type 1 (HSV-1)
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 10 µL
Comments In Vitro Diagnostic Use

LIAISON® Control HSV-1 IgG

310831

Material provided Two levels x 2 vials each 40 determinations per vial

LIAISON® Treponema Serum Controls

310842

Material provided Two levels x 2 vials each 20 determinations per vial

LIAISON® Borrelia burgdorferi

310870

Intended Use For the qualitative determination of IgG and IgM antibodies to Borrelia burgdorferi
Material provided Reagent Integral for 100 determinations. Diluent included
Method 2-step chemiluminescent immunoassay using coated magnetic microparticles
Calibrators Included
Incubation 20 minutes
Sample Type Serum
Sample Size 5 µL
Comments In Vitro Diagnostic Use

LIAISON® Borrelia burgdorferi Serum Controls

310871

Material provided Two levels x 2 vials each 40 determinations per vial

ETI-Measles IgG ELISA

4601/96 Wells

Intended Use For the semi-quantitative detection of IgG antibodies to Measles Virus
Label HRP
Incubation 30 min + 30 min + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum
Sample Size 100 µL of 1:101 dilution
Comments In Vitro Diagnostic Use

ETI-Varicella Zoster (VZV) IgG ELISA

4621/96 Wells

Intended Use For the qualitative and semi-qualitative detection of IgG antibodies to Varicella Zoster Virus
Label HRP
Incubation 30 min + 30 min + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum
Sample Size 100 µL of 1:101 dilution
Comments In Vitro Diagnostic Use

ETI-Mumps IgG ELISA

4631/96 Wells

Intended Use For the qualitative and semi-quantitative determination of IgG antibodies to Mumps Virus
Label HRP
Incubation 30 min + 30 min + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum
Sample Size 100 µL of 1:21 dilution
Comments In Vitro Diagnostic Use

ETI-H. pylori IgG

4651/96 Wells

Intended Use For the qualitative determination of IgG antibodies to H. pylori antigen
Label HRP
Incubation 30 min + 30 min + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum
Sample Size 100 µL of 1:21 dilution
Comments In Vitro Diagnostic Use

Cytomegalovirus (CMV) IgG ELISA

720-320/96 Wells

Intended Use For the qualitative and semi-quantitative detection of IgG antibodies to Cytomegalovirus
Label HRP
Incubation 60 + 60 + 20 min/37°C
Chromogen/Substrate TMB
Sample Type Serum
Sample Size 100 µL of 1:101 dilution
Comments In Vitro Diagnostic Use

Cytomegalovirus (CMV) IgM Capture ELISA

720-330/96 Wells

Intended Use For the qualitative detection of IgM antibodies to CMV
Label HRP
Incubation 60 + 60 + 20 min/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum
Sample Size 100 µL of 1:101 dilution
Comments In Vitro Diagnostic Use

HSV 1&2 IgG ELISA

720-340/96 Wells

Intended Use For qualitative and semi-quantitative detection of IgG antibodies to HSV Type 1 and/or Type 2
Label HRP
Incubation 60 min + 60 min + 20 min/37°C
Chromogen/Substrate TMB
Sample Type Serum
Sample Size 100 µL of 1:101 dilution
Comments In Vitro Diagnostic Use

Ortho® HCV 3.0 ELISA

930740/480 Wells

Intended Use For the detection of antibody to Hepatitis C Virus (anti-HCV)
Label HRP
Incubation 1 hr/37°C + 1 hour/37°C + 30 min/RT
Chromogen/Substrate OPD
Sample Type Serum/Plasma
Sample Size 210 µL of 1:21 dilution
Comments In Vitro Diagnostic Use

HBsAg Confirmatory PLUS

N0143/44 Tests

Intended Use Confirmatory assay for Hepatitis B Surface Antigen (HBsAg)
Sample Type Serum/Plasma
Comments In Vitro Diagnostic Use

ETI-HA-IgMK PLUS (IgM anti-HAV)

P001925/96 Wells

Intended Use For the detection of IgM antibodies to Hepatitis A virus
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 100 µL of 1:100 dilution
Comments In Vitro Diagnostic Use

ETI-AB-HAVK PLUS (anti-HAV)

P001926/96 Wells

Intended Use For the detection of total antibodies to Hepatitis A virus
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 50 µL
Comments In Vitro Diagnostic Use

ETI-AB-COREK PLUS (anti-HBc)

P001927/192 Wells

Intended Use For the detection of total antibodies to Hepatitis B core antigen (anti-HBc)
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 50 µL
Comments In Vitro Diagnostic Use

ETI-CORE-IgMK PLUS (IgM anti-HBc)

P001928/96 Wells

Intended Use For the detection of IgM antibodies to Hepatitis B core antigen (IgM anti-HBc)
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 100 µL of (1:4000) dilution
Comments In Vitro Diagnostic Use

ETI-AB-EBK PLUS (anti-HBe)

P001929/96 Wells

Intended Use For the detection of antibodies to Hepatitis B(e) antigen (AntiHBe)
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 50 µL
Comments In Vitro Diagnostic Use

ETI-EBK PLUS (HBeAg)

P001930/96 Wells

Intended Use For the detection of Hepatitis B(e) antigen (HBeAg)
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 100 µL
Comments In Vitro Diagnostic Use

ETI-AB-AUK PLUS (anti-HBs)

P001931/192 Wells

Intended Use For the detection of antibodies to Hepatitis B surface antigen (anti-HBs)
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 100 µL
Comments In Vitro Diagnostic Use

ETI-MAK-2 PLUS (HBsAg)

P001932/192 Wells

Intended Use For the detection of Hepatitis B surface antigen (HBsAg)
Label HRP
Incubation 2 hrs/37°C + 1 hr/37°C + 30 min/RT
Chromogen/Substrate TMB
Sample Type Serum/Plasma
Sample Size 100 µL
Comments In Vitro Diagnostic Use

Anti-HBs Quant AB AU Standard Set

P001936

Intended Use Standard set anti-HBs (5-160 mIU/mL; WHO 1st reference preparation 1977)
Sample Type Serum/Plasma
Comments ASR: Analyte Specific Reagent analytical and performance characteristics are not established. Not for donor screening

TREP-SURE™ Syphilis Screen

TS96/96 Wells

Intended Use For the in vitro diagnostic detection of (Treponema pallidum) Antibodies (Syphilis)
Label HRP
Incubation 60 min + 30 min + 15 min/37°C
Chromogen/Substrate TMB
Sample Type Serum or EDTA and Citrated Plasma
Sample Size 100 µL
Comments In Vitro Diagnostic Use